An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Beijing Tian Tan Hospital, Capital Medical University, Beijing, Beijing, China
Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
Beijing Tian Tan Hospital, Capital Medical University, Beijing, Beijing, China
Ain Shams University, Cairo, Egypt
Karolinska University Hospital, Stockholm, Sweden
Sharurah Armed Forces Hospital, Sharurah, Najran, Saudi Arabia
Heart Institute (InCor), Univ. of Sao Paulo Medical School, Sao Paulo, Brazil
Nova Esperança University Hospital, João Pessoa, Paraíba, Brazil
Clinique Médipôle Garonne, Toulouse, Haute-Garonne, France
faculty of medicine, Zagazig university, Zagazig, Elsharqya, Egypt
Far Eastern Memorial Hospital, New Taipei City, Taiwan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.